Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagaraj Manickam

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Lipid and Atherosclerosis|October 6, 2023
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic RatsSaravanakumar Sundararajan, Isaivani Jayachandran, Gautam Kumar Pandey, et al.
Scientific Reports|February 21, 2020
Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathyDharmeshkumar Parmar, Nivedita Bhattacharya, Shanthini Kannan, et al.
Diabetes Technology & Therapeutics|June 12, 2020
Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from LockdownRanjit Mohan Anjana, Rajendra Pradeepa, Mohan Deepa, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Lipid and Atherosclerosis|October 6, 2023
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic RatsSaravanakumar Sundararajan, Isaivani Jayachandran, Gautam Kumar Pandey, et al.
Scientific Reports|February 21, 2020
Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathyDharmeshkumar Parmar, Nivedita Bhattacharya, Shanthini Kannan, et al.
Diabetes Technology & Therapeutics|June 12, 2020
Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from LockdownRanjit Mohan Anjana, Rajendra Pradeepa, Mohan Deepa, et al.
Pageof 2